Full Year 2021 Hikma Pharmaceuticals PLC Earnings Presentation - Pre-Recorded Transcript

Feb 24, 2022 / 07:00AM GMT
Presentation - Pre-Recorded
Feb 24, 2022 / 07:00AM GMT

=====================
Corporate Participants
=====================
* Khalid Waleed Hosny Al Nabilsi
Hikma Pharmaceuticals PLC - CFO
* Sigurdur Oli Olafsson
Hikma Pharmaceuticals PLC - CEO & Executive Director

=====================
Sigurdur Oli Olafsson - Hikma Pharmaceuticals PLC - CEO & Executive Director

Hello, everyone. I'm Siggi Olafsson, CEO of Hikma Pharmaceuticals. And I'm here with Khalid Nabilsi, our CFO. Thank you for joining our 2021 full year results presentation.

I will provide a quick summary of our results and an update to our strategic progress before handing over to Khalid to run through the financial details.

I'm really pleased to announce a strong set of numbers for 2021. While the year presented ongoing challenges as a result of the pandemic, we executed our strategy extremely well, delivering 9% group core revenue growth and 10% group core operating profit expansion. This reflects a strong performance of our 3 business segment; and led

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot